Skip to content

WHWK WHWK Operating lease liabilities

Operating lease liabilities at other companies

Immunome logo
ImmunomeIMNM

Other financials

Income statement

See full
Revenue--100%
Gross profit--100%
Operating income-$23.5M-54.6%
Net income-$22.2M-130%
EPS (diluted)-$0.32-117%

Balance sheet

See full
Cash & equivalents$34.8M-84.7%
Total debt$833.0K-34.3%
Total equity$116.2M-47.6%
Total assets$127.2M-45.6%

Cash flow

See full
Operating cash flow-$22.2M-87.2%
CapEx--100%
Free cash flow-$22.2M-78.9%

Valuation

See full
Market cap$226.49M+131%

Profitability

See full
Gross margin89.4%+1.0pp
Operating margin-1,601.1%-1,985pp
Net margin-288.3%+61.6pp
FCF margin-1,371.4%-1,730pp

Returns & leverage

See full
Return on equity-68.5%-86.2pp
Debt / equity0.0×
Current ratio11.4×-7.6×

Where this comes from

Reported directly by WHWK in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: WHWK’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about WHWK's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is WHWK's operating lease liabilities?
WHWK (WHWK) reported operating lease liabilities of $0 in Q1 2026.
How has WHWK's operating lease liabilities changed year-over-year?
WHWK's operating lease liabilities increased by 100.0% year-over-year, from -$89K to $0.
What is the long-term trend for WHWK's operating lease liabilities?
Over 2 years (2021 to 2024), WHWK's operating lease liabilities has grown at a 99.2% compound annual growth rate (CAGR), from -$129K to -$512K.